↓ Skip to main content

Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis

Overview of attention for article published in European Journal of Clinical Microbiology & Infectious Diseases, November 2019
Altmetric Badge

Mentioned by

twitter
2 tweeters
Title
Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis
Published in
European Journal of Clinical Microbiology & Infectious Diseases, November 2019
DOI 10.1007/s10096-019-03768-9
Pubmed ID
Authors

Guangming Chen, Huabin Wang, Yanhong Wang

Abstract

At present, although it has made great progress in the diagnosis and treatment of tuberculosis, tuberculosis is still an important cause of morbidity and mortality. There were approximately 8.6 million new cases of tuberculosis in 2012, and approximately 1.3 million people died from tuberculosis. Early diagnosis and timely treatment are essential for controlling the spread of tuberculosis infection and reducing mortality. Conventional methods of Mycobacterium tuberculosis detection such as acid-fast staining microscopy and tuberculin skin test are widely used, but with low sensitivity or specificity. In recent years, a newly developed quantitative test, γ-interferon release test (IGRA), has been recognized and widely applied to the early diagnosis and monitoring of tuberculosis. QuantiFERON-TB Gold in-tube (QFT-GIT) is one of the mature IGRA methods. This paper summarizes the researches on QFT-GIT in recent years and introduces its principles, methodology, clinical application, and factors of uncertain results for the diagnosis and treatment of tuberculosis.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2019.
All research outputs
#11,166,985
of 14,083,335 outputs
Outputs from European Journal of Clinical Microbiology & Infectious Diseases
#1,564
of 2,080 outputs
Outputs of similar age
#186,964
of 262,504 outputs
Outputs of similar age from European Journal of Clinical Microbiology & Infectious Diseases
#26
of 35 outputs
Altmetric has tracked 14,083,335 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,080 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,504 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.